Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 5 minute read Healthcare Industry News Vivian Health transitions CEO role to Bill Kong as AI marketplace strategy gains traction Vivian Health names Bill Kong CEO as it enters a new AI-driven growth phase. Find out what this leadership change means for its business, strategy, and IAC. byVenkateshJanuary 30, 2026